A Win For AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. (AGE:NYSEMKT) rocketted at $1.2, a gain of 20%. The stock got featured on our News Catalysts scanner on Tue, Dec 14, 2021 at 11:52 AM in the 'PATNERSHIP' category. From Wed, Dec 22, 2021, the stock recorded 44.44% Up Days and 60.00% Green Days
The stock spiked on Fri, Dec 31, 2021 at $1.39 with a volume of 17M+.
About AgeX Therapeutics, Inc. (AGE:NYSEMKT)
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop innovative medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1 and AGEX-BAT1. And iTR drug-based therapeutic candidates in development are AGEX-iTR1547 and Renelon.
Top 10 Gainers:
- EAR (EAR:NASDAQ), 59.65%
- Alterity Therapeutics Limited (ATHE:NASDAQ), 33.82%
- China Natural Resources, Inc. (CHNR:NASDAQ), 27.79%
- Vocera Communications, Inc. (VCRA:NYSE), 26.63%
- NBTX (NBTX:NASDAQ), 22.21%
- IMAC Holdings, Inc. (IMAC:NASDAQ), 21.05%
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 20.05%
- Phunware, Inc. (PHUN:NASDAQ), 19.92%
- ENSC (ENSC:NASDAQ), 18.16%
- Magenta Therapeutics, Inc. (MGTA:NASDAQ), 16.14%